We are live on
!
Find out more
Eli Lilly
1,248 hedge funds and large institutions have $70.7B invested in Eli Lilly in 2017 Q1 according to their latest regulatory filings, with 108 funds opening new positions, 416 increasing their positions, 505 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 26 → 26 (0)
15% less call options, than puts
Call options by funds: $557M | Put options by funds: $653M
18% less repeat investments, than reductions
Existing positions increased: 416 | Existing positions reduced: 505
Holders
1,248
Holding in Top 10
26
Calls
$557M
Puts
$653M
Top Buyers
| 1 | +$4.8B | |
| 2 | +$276M | |
| 3 | +$249M | |
| 4 |
BGC
Beutel, Goodman & Co
Toronto,
Ontario, Canada
|
+$180M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$175M |
Top Sellers
| 1 | -$430M | |
| 2 | -$204M | |
| 3 | -$117M | |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$103M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$94.2M |